GANT61, a Hedgehog signaling inhibitor, could increase sorafenib sensitivity through inhibiting the expression level of CD44 and Hedgehog signaling in CD44(+) HCC PDOs [102]. Here, CD44 is linked to hepatocellular carcinoma.